ANGIOGENIC ENDOTHELIAL CELL DETECTION IN PERIPHERAL CIRCULATION IN METASTATIC DS
转移性 DS 外周循环中血管生成内皮细胞的检测
基本信息
- 批准号:7376350
- 负责人:
- 金额:$ 0.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-12-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a voluntary research study to see if a simple blood test can detect the presence of a gene in the blood which may be produced only by cancer cell blood vessels. Approximately 60 subjects will be enrolled into this study. There will be three groups of subjects. There will be 20 subjects that will consist of healthy individuals, 20 subjects with cancer that has spread from one area to another in the body and 20 subjects will be receiving treatment with a study drug called Octreother. Subjects in the first two groups will donate approximately 5cc of blood on one occasion. Subjects undergoing treatment with Octreother will donate approximately 5cc of blood prior to treatment and one after each treatment with Octreother (maximum three teaspoons).
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。这是一项自愿性研究,旨在了解一项简单的血液测试是否可以检测出血液中可能仅由癌细胞血管产生的基因。 本研究将入组约60例受试者。将有三组主题。将有20例受试者包括健康个体、20例癌症从身体的一个区域扩散到另一个区域的受试者和20例接受研究药物Octreother治疗的受试者。 前两组中的受试者将一次献血约5 cc。接受Octreother治疗的受试者将在治疗前献血约5 cc,每次Octreother治疗后献血1 cc(最多3茶匙)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUGENE A WOLTERING其他文献
EUGENE A WOLTERING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUGENE A WOLTERING', 18)}}的其他基金
TRIAL TO COMPARE ADJUVANT ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN BREAST CANCER PTS
比较阿霉素和环磷酰胺辅助治疗乳腺癌 PTS 的试验
- 批准号:
7376252 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL COMPARING ADJUVANT CLODRONATE THERAPY VERSUS PLACEBO EARLY BREAST CANCER
比较氯膦酸盐辅助治疗与安慰剂治疗早期乳腺癌的试验
- 批准号:
7376347 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL COMPARING SIX CYLES OF FEC TO FOUR CYCLES OF AC IN BREAST CANCER
比较乳腺癌中六周期 FEC 与四周期 AC 的试验
- 批准号:
7376310 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
NSABP B-27:TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE/CANCER OF BREAST
NSABP B-27:比较术前 AC 与随后使用泰索帝/乳腺癌的 AC 的试验
- 批准号:
7376234 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL COMPARING 5-FU PLUS LEUCOVORIN AND OXALIPLATIN IN CARCINOMA OF THE COLON
比较 5-FU 加亚叶酸和奥沙利铂治疗结肠癌的试验
- 批准号:
7376243 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
THREE CHEMOTHERAPY REGIMENS IN WOMEN WITH NODE-POSITIVE BREAST CANCER
女性淋巴结阳性乳腺癌的三种化疗方案
- 批准号:
7376337 - 财政年份:2005
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL TO COMPARE ADJUVANT ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN BREAST CANCER PTS
比较阿霉素和环磷酰胺辅助治疗乳腺癌 PTS 的试验
- 批准号:
7203997 - 财政年份:2004
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL COMPARING 5-FU PLUS LEUCOVORIN AND OXALIPLATIN IN CARCINOMA OF THE COLON
比较 5-FU 加亚叶酸和奥沙利铂治疗结肠癌的试验
- 批准号:
7203985 - 财政年份:2004
- 资助金额:
$ 0.02万 - 项目类别:
TRIAL COMPARING SIX CYLES OF FEC TO FOUR CYCLES OF AC IN BREAST CANCER
比较乳腺癌中六周期 FEC 与四周期 AC 的试验
- 批准号:
7204079 - 财政年份:2004
- 资助金额:
$ 0.02万 - 项目类别:
NSABP B-27:TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE/CANCER OF BREAST
NSABP B-27:比较术前 AC 与随后使用泰索帝/乳腺癌的 AC 的试验
- 批准号:
7203969 - 财政年份:2004
- 资助金额:
$ 0.02万 - 项目类别:
相似海外基金
eNOS regulates endothelial cell polarity and angiogenic sprouting in vascular pathologies
eNOS 调节血管病理中的内皮细胞极性和血管生成
- 批准号:
451381 - 财政年份:2021
- 资助金额:
$ 0.02万 - 项目类别:
Operating Grants
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10028453 - 财政年份:2020
- 资助金额:
$ 0.02万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10414086 - 财政年份:2020
- 资助金额:
$ 0.02万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10618247 - 财政年份:2020
- 资助金额:
$ 0.02万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10252906 - 财政年份:2020
- 资助金额:
$ 0.02万 - 项目类别:
Establishment of a novel anti-angiogenic treatment targeting Tumor endothelial cell specific non-coding RNA
建立针对肿瘤内皮细胞特异性非编码RNA的新型抗血管生成疗法
- 批准号:
18K15831 - 财政年份:2018
- 资助金额:
$ 0.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Compartmented cAMP signalling Regulates Human Arterial Endothelial Cell Inflammatory and Angiogenic Responses
区室 cAMP 信号传导调节人动脉内皮细胞炎症和血管生成反应
- 批准号:
369092 - 财政年份:2017
- 资助金额:
$ 0.02万 - 项目类别:
Operating Grants
Ex vivo angiogenic cell expansion system increases the number and vasculogenic potential of endothelial progenitor cells by switching the culture gravity condition
离体血管生成细胞扩增系统通过切换培养重力条件增加内皮祖细胞的数量和血管生成潜力
- 批准号:
16K20370 - 财政年份:2016
- 资助金额:
$ 0.02万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
使用源自肾细胞癌的肿瘤相关内皮细胞开发新的抗血管生成药物筛选系统
- 批准号:
20591847 - 财政年份:2008
- 资助金额:
$ 0.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Angiogenic Therapy for Renal Failure with Platelet-derived Endothelial Cell Growth Factor in Rat
血小板源性内皮细胞生长因子对大鼠肾衰竭的血管生成治疗
- 批准号:
19592088 - 财政年份:2007
- 资助金额:
$ 0.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)